Qube Research & Technologies LTD Arbutus Biopharma Corp Transaction History

Qube Research & Technologies LTD

  • $93.8 Billion
  • Q2 2025

A detailed history of Qube Research & Technologies LTD transactions in Arbutus Biopharma Corp stock. As of the latest transaction made, Qube Research & Technologies LTD holds 368,030 shares of ABUS stock, worth $1.65 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
368,030
Previous 295,341 24.61%
Holding current value
$1.65 Million
Previous $1.03 Million 10.39%
% of portfolio
0.0%
Previous 0.0%

Shares

16 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2025

Aug 14, 2025
BUY
$2.88 - $3.61 $209,344 - $262,407
72,689 Added 24.61%
368,030 $1.14 Million
Q1 2025

May 15, 2025
SELL
$3.06 - $3.59 $290,687 - $341,035
-94,996 Reduced 24.34%
295,341 $1.03 Million
Q4 2024

Feb 14, 2025
BUY
$3.18 - $4.2 $699,759 - $924,210
220,050 Added 129.22%
390,337 $1.28 Million
Q3 2024

Nov 14, 2024
BUY
$3.12 - $4.56 $531,295 - $776,508
170,287 New
170,287 $655,000
Q4 2023

Feb 13, 2024
SELL
$1.69 - $2.54 $11,030 - $16,578
-6,527 Reduced 79.48%
1,685 $4,000
Q3 2023

Nov 13, 2023
SELL
$1.9 - $2.27 $17,035 - $20,352
-8,966 Reduced 52.19%
8,212 $16,000
Q2 2023

Aug 14, 2023
SELL
$2.24 - $3.06 $10,855 - $14,828
-4,846 Reduced 22.0%
17,178 $39,000
Q1 2023

May 15, 2023
BUY
$2.23 - $3.1 $49,113 - $68,274
22,024 New
22,024 $66,000
Q3 2021

Nov 12, 2021
SELL
$2.65 - $4.62 $41,006 - $71,489
-15,474 Closed
0 $0
Q2 2021

Aug 13, 2021
SELL
$2.5 - $3.51 $262,637 - $368,743
-105,055 Reduced 87.16%
15,474 $47,000
Q1 2021

May 14, 2021
SELL
$3.14 - $4.84 $828,231 - $1.28 Million
-263,768 Reduced 68.64%
120,529 $401,000
Q4 2020

Feb 16, 2021
BUY
$2.76 - $4.97 $947,295 - $1.71 Million
343,223 Added 835.62%
384,297 $1.36 Million
Q3 2020

Nov 12, 2020
SELL
$1.75 - $6.2 $31,218 - $110,601
-17,839 Reduced 30.28%
41,074 $129,000
Q2 2020

Aug 14, 2020
BUY
$0.91 - $2.36 $13,644 - $35,385
14,994 Added 34.14%
58,913 $107,000
Q1 2020

May 15, 2020
SELL
$1.01 - $3.42 $123,441 - $417,988
-122,219 Reduced 73.56%
43,919 $44,000
Q4 2019

Feb 13, 2020
BUY
$0.87 - $2.89 $144,540 - $480,138
166,138 New
166,138 $462,000

Others Institutions Holding ABUS

# of Institutions
182
Shares Held
118M
Call Options Held
1M
Put Options Held
478K
View Full List

About Arbutus Biopharma Corp

ABUS Quotes by TradingView
  • Ticker ABUS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 149,951,008
  • Market Cap $673M
  • Description
  • Arbutus Biopharma Corporation, a biopharmaceutical company, develops novel therapeutics for chronic Hepatitis B virus (HBV) infection, SARS-CoV-2, and other coronaviruses in the United States. Its HBV product pipeline consists of AB-729, a proprietary subcutaneously delivered RNA interference product candidate, which in Phase Ia/Ib clinical tria...
More about ABUS
Track This Portfolio

Track Qube Research & Technologies LTD Portfolio

Follow Qube Research & Technologies LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Qube Research & Technologies LTD, based on Form 13F filings with the SEC.

News

Stay updated on Qube Research & Technologies LTD with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email